Small fibers, large impact: Quality of life in small-fiber neuropathy

Muscle and Nerve

Volumn 49, Issue 3, 2014, Pages 329-336

  Bakkers, Mayienne ^a   Faber, Catharina G ^a   Hoeijmakers, Janneke G J ^a   Lauria, Giuseppe ^b   Merkies, Ingemar S J ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c Department of Orthopaedic Surgery   (Netherlands)

Author keywords

Clinimetric evaluation; Pain; Polyneuropathy; Quality of life; Small fiber neuropathy

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; EVALUATION STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCLE CELL; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PAIN ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SHORT FORM 36; SMALL FIBER NEUROPATHY; SWEATING; SYMPTOMS INVENTORY QUESTIONNAIRE; VERY ELDERLY; VISUAL ANALOG SCALE; XEROSTOMIA; YOUNG ADULT;

CLINIMETRIC EVALUATION; PAIN; POLYNEUROPATHY; QUALITY OF LIFE; SMALL-FIBER NEUROPATHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SENSORY THRESHOLDS; THYROTROPIN; VISUAL ANALOG SCALE; YOUNG ADULT;

EID: 84893901492     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23910     Document Type: Article

References (50)

1. Hoeijmakers JG, Faber CG, Lauria G, Merkies IS, Waxman SG. Small-fibre neuropathies-advances in diagnosis, pathophysiology and management. Nat Rev Neurol 2012;8:369-379.
2. Lacomis D. Small-fiber neuropathy. Muscle Nerve 2002;26:173-188.
3. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011;378:31-40.
4. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002;18:350-354.
5. Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004;21:976-982.
6. Vlckova-Moravcova E, Bednarik J, Belobradkova J, Sommer C. Small-fibre involvement in diabetic patients with neuropathic foot pain. Diabet Med 2008;25:692-699.
7. Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010;17:903-912.
8. Holland NR, Stocks A, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology 1997;48:708-711.
9. Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 1998;44:47-59.
10. Said G. Small fiber involvement in peripheral neuropathies. Curr Opin Neurol 2003;16:601-602.
11. Sommer C, Lauria G. Painful small-fiber neuropathies. Handb Clin Neurol 2006;81:621-633.
12. Lauria G. Small fibre neuropathies. Curr Opin Neurol 2005;18:591-597.
13. Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 2008;131:1912-1925.
14. Hoitsma E, Reulen JP, de Baets M, Drent M, Spaans F, Faber CG. Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci 2004;227:119-130.
15. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33:2285-2293.
16. Lauria G, Lombardi R. Skin biopsy: a new tool for diagnosing peripheral neuropathy. BMJ 2007;334:1159-1162.
17. Jamal GA, Hansen S, Weir AI, Ballantyne JP. The neurophysiologic investigation of small fiber neuropathies. Muscle Nerve 1987;10:537-545.
18. Nebuchennykh M, Loseth S, Lindal S, Mellgren SI. The value of skin biopsy with recording of intraepidermal nerve fiber density and quantitative sensory testing in the assessment of small fiber involvement in patients with different causes of polyneuropathy. J Neurol 2009;256:1067-1075.
19. Vlckova-Moravcova E, Bednarik J, Dusek L, Toyka KV, Sommer C. Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve 2008;37:50-60.
20. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998;51:1055-1068.
21. Ware JE Jr, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1167-1170.
22. Ware JE Jr, Kosinski M, Gandek B. SF-36® Health Survey. Manual and interpretation guide. Santa Monica, CA: RAND Corporation; 2000.
23. Ware JE Jr, Kosinski M, Keller DS. SF-36 physical and mental health summary scales: a user's manual. Boston, MA: The Health Assessment Lab, New England Medical Center; 1994.
24. Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, Devigili G, et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 2010;15:202-207.
25. Yarnitsky D, Sprecher E. Thermal testing: normative data and repeatability for various test algorithms. J Neurol Sci 1994;125:39-45.
26. Hoitsma E, Drent M, Verstraete E, Faber CG, Troost F, Spaans J, Reulen JP. Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis. Clin Neurophysiol 2003;114:2326-2333.
27. Martina IS, van Koningsveld R, Schmitz PI, van der Meche FG, van Doorn PA. Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. J Neurol Neurosurg Psychiatry 1998;65:743-747.
28. Bakkers M, Merkies IS, Lauria G, Devigili G, Penza P, Lombardi R, et al. Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 2009;73:1142-1148.
29. Reulen JP, Lansbergen MD, Verstraete E, Spaans F. Comparison of thermal threshold tests to assess small nerve fiber function: limits vs. levels. Clin Neurophysiol 2003;114:556-563.
30. Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, Giuliani MJ, et al. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003;60:898-904.
31. Yarnitsky D, Sprecher E, Zaslansky R, Hemli JA. Heat pain thresholds: normative data and repeatability. Pain 1995;60:329-332.
32. Maxwell C. Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment. Br J Clin Pharmacol 1978;6:15-24.
33. Herndon JE, Harrell FE Jr. The restricted cubic spline hazard model. Commun Stat Theory Methods 1990;19:639-663.
34. Padua L, Schenone A, Aprile E, Benedetti L, Caliandro P, Tonali P, et al. Quality of life and disability assessment in neuropathy: a multicentre study. J Peripher Nerve Syst 2005;19:3-10.
35. Tavee J, Zhou L. Small fiber neuropathy: a burning problem. Cleve Clin J Med 2009;76:297-305.
36. van Acker K, Bouhassira D, De Baquer D, Weiss S, Matthys K, Raemen H, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab 2009;35:206-213.
37. Erdmann PG, Genderen van FR, Teunissen LL, Notermans NC, Lindeman E, van Wijck AJ, van Meeteren NL. Pain in patients with chronic idiopathic axonal polyneuropathy. Eur Neurol 2010;64:58-64.
38. Hughes RAC, Umapathi T, Gray IA, Gregson NA, Noori M, Pannala AS, et al. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 2004;127:1723-1730.
39. Liedberg GM, Vrethem M. Polyneuropathy, with and without neurogenic pain, and its impact on daily life activities-a descriptive study. Disabil Rehabil 2009;31:1402-1408.
40. Kim BJ, Park HR, Roh HJ, Jeong DS, Kim BS, Park KW, et al. Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma. Qual Life Res 2010;19:1097-1103.
41. Ku DY, Park YS, Chang HJ, Kim SR, Ryu JW, Kim WJ. Depression and life quality in chronic renal failure patients with polyneuropathy on hemodialysis. Ann Rehabil Med 2012;36:702-707.
42. Poliakov I, Toth C. The impact of pain in patients with polyneuropathy. Eur J Pain 2011;15:1015-1022.
43. Kempen GI, Ormel J, Brilman EI, Relyveld J. Adaptive responses among Dutch elderly: the impact of eight chronic medical conditions on health-related quality of life. Am J Publ Health 1997;87:38-44.
44. Lindh J, Tondel M, Persson B, Vrethem B. Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population. Disabil Rehabil 2011;33:617-623.
45. Teunissen LL, Eurelings M, Notermans NC, Hop JW, van Gijn J. Quality of life in patients with axonal polyneuropathy. J Neurol 2000;247:195-199.
46. Merkies IS, Schmitz PI, Samijn JP, van der Meche FG, van Doorn PA. Fatigue in immune-mediated polyneuropathies. Neurology 1999;53:1648-1654.
47. Viala-Danten M, Martin S, Guillemin I, Hays RD. Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial. Health Qual Life Outcomes 2008;6:113.
48. Vickrey BG, Hays RD, Beckstrand M. Development of a health-related quality of life measure for peripheral neuropathy. Neurorehabil Neural Repair 2000;14:93-104.
49. Merkies IS, Bril V, Dalakas MC, Deng C, Donofrio P, Hanna K, et al. Health related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE study. Neurology 2009;72:1337-1344.
50. Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA. Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 2002;59:84-91.